Adaptin Bio (APTN) EPS (Basic) (2023 - 2026)
Adaptin Bio recorded quarterly EPS (Basic) of -$0.13 in Q1 2026, up 18.75% quarter-over-quarter from -$0.16 in Q4 2025, and down 30.0% year-over-year from -$0.19 in Q1 2025.
Adaptin Bio's EPS (Basic) history runs 4 years deep, the most recent figure standing at -$0.13 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 30.0% year-over-year to -$0.13; the TTM figure through Mar 2026 stood at -$0.67 (up 29.47% YoY), while the FY2025 annual figure was -$0.66, up 31.25% from the prior year.
- EPS (Basic) came in at -$0.13 for Q1 2026 at Adaptin Bio, up from -$0.16 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q1 2023 to a low of -$0.34 in Q3 2024.
- A 4-year average of -$0.13 and a median of -$0.13 in 2026 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 24900.0% in 2024 and jumped 41.18% in 2025, its largest moves.
- Adaptin Bio's EPS (Basic) stood at -$0.01 in 2023, then tumbled by 3614.29% to -$0.26 in 2024, then jumped by 38.46% to -$0.16 in 2025, then advanced by 18.75% to -$0.13 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.13, -$0.16, and -$0.2 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.20 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.10 |
| Dec 31, 2024 | -0.26 |
| Sep 30, 2024 | -0.34 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |